All posts by imreal

A Way into Your Soul with Poetry, Prayer and The Lord Jesus” is an inspiring and vibrant poetic experience


News Image

“Gospel Poetics: A Way into Your Soul with Poetry, Prayer and The Lord Jesus”: a spiritually inspiring examination of St. Matthew’s Gospel. “Gospel Poetics: A Way into Your Soul with Poetry, Prayer and The Lord Jesus” is the creation of published author Frederick Preston Annie, who was born on a small family farm near Coal Mountain, West Virginia. Annie has been a student of architecture, literature, and theology and has served as a Catholic priest for over forty years. In 2006, he was named a Prelate of Honor by Pope Benedict XVI. He is now retired and resides in Charleston, West Virginia.

Annie shares, “This book of poetry is an opportunity to search for meaning in the Gospel of St. Matthew and a way to explore your soul.

“St. Mathew’s Gospel is a rich and fertile field producing abundant insights into life and the human condition. These poems cultivate this wisdom and translate it into poetry, amplifying its meaning and adding contemporary context and color. Once engaged in the poetic, the reader is offered additional insights generated by their own excited imagination. To aid the imagination, I have added an original abstract painting to each poem to enhance the experience.

“This experience of the Holy can be a path into the soul. Deep at the bottom of each of us is that spark of eternity that can only be ignited by the gift of faith. It is my hope that these poems will encourage the reader to examine that divine mystery that is planted deep within us by the very Word of God.”

Published by Christian Faith Publishing, Frederick Preston Annie’s new book will uplift and encourage readers in their faith while offering a fresh experience with the Gospel of St. Matthew.

Annie draws from a lifetime of biblical study and prayer to bring readers an encouraging message of fulfillment found within faith.

Consumers can purchase “Gospel Poetics: A Way into Your Soul with Poetry, Prayer and The Lord Jesus” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Gospel Poetics: A Way into Your Soul with Poetry, Prayer and The Lord Jesus,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Short-Term Study of Ecopipam Shows Reduction of Tics in Children with Tourette Syndrome


International Congress of Parkinson’s Disease and Movement Disorders ®

International Congress of Parkinson’s Disease and Movement Disorders ®

“No other drug confirmed effectiveness in randomized controlled trials since the addition of aripiprazole to the therapeutic arsenal of TS. This phase 2b randomized trial breaks the spell.”

A recent study evaluated the efficacy and safety of a pharmaceutical treatment, ecopipam, for children with Tourette syndrome (TS), according to a study released today at the International Congress of Parkinson’s Disease and Movement Disorders® in Madrid, Spain. (Mahableshwarkar et al., 2022)

Ecopipam works by selectively reducing the response to dopamine in neurons. Importantly, ecopipam is known for having a low incidence of adverse effects and was well-tolerated during the study. The double-blind study lasted 12 weeks and examined children with Tourette’s ranging from 6 to 17 years old. During the study, reductions in both motor and phonic tics compared to the placebo control group were reported. These promising results will require follow-up, longer-term studies.

Davide Martino, MD, PhD, Associate Professor in the Department of Clinical Neurosciences at the University of Calgary, commented, “Despite several new or re-purposed medications appeared promising for the treatment of tics in recent years, no other drug confirmed effectiveness in randomized controlled trials since the addition of aripiprazole to the therapeutic arsenal of Tourette syndrome. This phase 2b randomized trial breaks the spell by showing significant superiority to placebo of a first-in-class selective dopamine D1 receptor antagonist, ecopipam, in reducing tic severity in children and adolescents with TS. This study is relevant for its adequate sample size and selection of primary and secondary outcomes. Ecopipam showed superiority to placebo in reducing tic severity, based on both clinician’s and caregiver’s impression, but did not differ from placebo in reducing quality of life. This is not surprising, given that quality of life in TS is often influenced more by comorbid symptoms like those related to attention deficit hyperactivity disorder, obsessive-compulsive disorder, anxiety and depression.”

Martino continues, “The treatment duration, albeit standard for clinical trials in tic disorders, was not very long and the observed difference from placebo was not large, hence longer-term monitoring of response and tolerability will be necessary. The side effect profile of ecopipam was also reassuring from this study, with the only caveat that tremor and parkinsonism were not specifically measured. Overall, this phase 2b study generates hope and supports that ecopipam deserves further investigation as a new treatment option for tics in TS.”

View abstract full text:

http://www.mdsabstracts.org

Reference #: 917

*View all 6 of today’s breaking International Congress research news releases:

https://www.movementdisorders.org/MDS/News/Newsroom.htm

# # #

About the 2022 MDS International Congress of Parkinson’s Disease and Movement Disorders®:

The MDS International Congress is the premier annual event to advance the clinical and scientific discipline of Movement Disorders, including Parkinson’s disease. Convening thousands of leading clinicians, scientists and other health professionals from around the globe, the International Congress will introduce more than 1,500 original scientific abstracts and provide a forum for education and collaboration on latest research findings and state-of-the-art treatment options.

About the International Parkinson and Movement Disorder Society:

The International Parkinson and Movement Disorder Society (MDS), an international society of over 11,000 clinicians, scientists, and other healthcare professionals, is dedicated to improving patient care through education and research. For more information about MDS, visit http://www.movementdisorders.org.

REFERENCES

Mahableshwarkar, A. et al. (2022, September 15). Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study of Ecopipam in Children and Adolescents with Tourette Syndrome [abstract]. In: Movement Disorders journal online supplement; International Congress of Parkinson’s Disease and Movement Disorders®. Retrieved from https://www.mdsabstracts.org/, Reference #917.

Share article on social media or email:

Rev. Dr. RonDerrick Johnson’s newly released “Power of the Christ Advantage” is an inspiring personal story of overcoming life’s challenges and living in faith


News Image

“Power of the Christ Advantage”: an empowering message of hope for those facing life’s pitfalls. “Power of the Christ Advantage” is the creation of published author Rev. Dr. RonDerrick Johnson, a graduate of four Christian universities and pastor of the Church of the Christ Advantage with nearly fifteen years as an educator in one of the largest school districts in America.

Rev. Dr. Johnson shares, “From deep inside the dungeon of a jail cell, Rev. Dr. RonDerrick Johnson gives birth to one of the most captivating stories of human perseverance. The Power of the Christ Advantage leaves audiences stunned as he unravels a sinister plot by his former fiancée and her accomplice to place him behind bars for life. The author gives one fascinating account after another of extreme poverty, horrendous abuse, near-death experiences, and ultimate betrayal—all while ascending to the pinnacle of education.

“This one-of-a-kind work is like nothing you have ever read before, as it gives a firsthand illustration of a systemically broken justice system. The magnetizing imagery will provoke fear, sadness, joy, and most certainly anger. A shocking twist is discovered when readers learn that the entire book was written while awaiting trial.

“No one is left untouched as Dr. Johnson heroically relies upon his faith in God to stand against a judicial giant that boasts over 125 years of prosecuting suspects. The Power of the Christ Advantage is a genuine David vs. Goliath story that will transform your faith in Christ forever.”

Published by Christian Faith Publishing, Rev. Dr. RonDerrick Johnson’s new book offers a deeply personal look into some of the author’s most challenging memories.

Rev. Dr. Johnson shares in hopes of helping others to keep the faith and hold true to what is right no matter what trials await.

Consumers can purchase “Power of the Christ Advantage” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Power of the Christ Advantage,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Breaking Out of Fear” is a powerful testimony of the author’s personal experience with God


News Image

“The Encounter: Breaking Out of Fear”: a powerful testament to the power of the Holy Spirit. “The Encounter: Breaking Out of Fear” is the creation of published author Lizette Gallagher.

Gallagher shares, “I honestly hope this book would inspire you in your journey with the Lord. The purpose of this book was to let others know God’s existence, let others know how God can just come into your life and show his existence.

“I remember when he first appeared to me, he showed me the words that I had written on the book and then showed me the vision of a huge bridge, and in the vision, the bridge was made out of the cross, and inside the bridge were the words he instructed me to share with the world, and He wanted me to let everyone know we all already have everything we need to continue walking with God inside that bridge, but in order to receive it, we have to believe in God to enter. We must surrender to God, so therefore we must die from self, to live for God. I know it is not easy, but if you believe in his word and if you surrender and allow the Holy Spirit to enter, the Holy Spirit will guide you into all truth, and when you know the truth, then and only then, you shall be set free. So trust and know that the Lord has set us apart.

“So when you are through with this book, you will see the words that the Father has spoken that had not yet been heard on earth, and then you shall know that the Lord is the Lord and his existence is real.

“God bless you.”

Published by Christian Faith Publishing, Lizette Gallagher’s new book is an empowering message of faith for those facing uncertainty.

Gallagher brings a fresh and open discussion of God’s intervention within her life in hopes of encouraging and helping others.

Consumers can purchase “The Encounter: Breaking Out of Fear” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “The Encounter: Breaking Out of Fear,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Real, published by WestBow Press, is a new book about rewilding church and ministry from the inside out


Real - Rewilding ministry from the inside out by Earl Buchan

Available at all online retailers in hardcover, softcover, and ebook.

This is a book about building up the person, you, me, those of us who know we are called to a kingdom life. Real, is a book about rewilding ministry from the inside-out.

Book Launch!

Earl Buchan, a pastor and church planter, shares encouragement for all those looking around and saying to themselves “there must be more than this.” It all begins with a fearless searching of our hearts to rewild ministry from the inside-out.

He looks to the Bible and over twenty years’ experience in the church to share from his own successes and failures sharing wisdom, warnings, and reminders of why we are meant to be in Christ. Earl shares that it all starts with us, live a life of openness and it will change the atmosphere in our churches and in our homes.

As you read, you’ll get answers to questions such as:

What can you really expect when you enter ministry?

Why is it so important to be your authentic self in all circumstances?

What are the costs to living His will, His way?

How can we overcome ourselves so people see more of Jesus and less of us?

This journey is not for the faint of heart, or those full of themselves. The author has been both, and he shares how the Lord rewilded his own heart in order to reveal the beauty of a called life.

About the Author

Earl Buchan is lead pastor of a Calvary Chapel called Radiant Church in Winnipeg, Manitoba, Canada.

A church planter and adventurer, he has spent a life in various forms of ministry. The calling he has pursued has led him to sidewalk evangelism, missions, soup kitchens, discipling, teaching, and leading his church. He is a husband, father, grandfather, and brother to many.

###

Share article on social media or email:

Dr. Kingsley R Chin Granted Patent To Add Wireless Sensor To AxioMed’s Total Disc Replacement To Target $23.50B Smart Medical Device Market


AxioMed’s Patent To Add Wireless Sensors issued in 2020

The patent provided a sensing artificial disc core having a top surface, a bottom surface, and at least one sidewall: at least one sensor disposed in or on the resilient core and a wireless transmitter configured to transmit signal representative of a sensed condition

On September 29, 2017, Dr. Kingsley R Chin and engineers working at KICVentures Group quietly submitted their patent application to add remote sensing capabilities to their AxioMed viscoelastic total disc replacement. On September 8, 2020 they were awarded patent # US 10,765,527 B2. This was a seismic accomplishment since it means AxioMed can now be marketed as a smart device with an integrated sensor that can communicate with an external device to report and store data such as spinal motion, track forces, disc function and any physiologic condition programmed within the sensor.

Market Research Future (MRFR) estimated the smart medical devices market to reach $23.50 billion by 2027 at a compound annual growth rate (CAGR) of 23.5 percent. Smart medical devices are game changing inventions at the forefront of digital healthcare providing life changing information that leads to diagnoses and treatments. Smart devices are wireless linked to smartphones making the patient and doctor more connected and able to store and retrieve data seamlessly.

“A data sensing circuit on the AxioMed disc adds to the other desirable and unique features such as multiple lordotic angles and the compressibility of the viscoelastic core,” says Vito Lore, VP of Innovations at KICVentures.

In a recent publication in Becker’s healthcare (Implantable sensors, advanced navigation could be next step for disc replacement) Dr. Michael Goldsmith was quoted as saying, “the next step with TDR will be to integrate sensors in the implant that can communicate motion, wear and possible loosening. This information will help alert the patient and the surgeon at an early stage when there may be a problem that warrants a visit to the surgeon.” Another surgeon Dr. Adam Kanter stated, “what I would really love is if the implant was able to communicate its movement and mechanistic ‘health’ through bluetooth or some other wireless/imageless mechanism.”

The patent provided a sensing artificial disc core having a top surface, a bottom surface, and at least one sidewall: at least one sensor disposed in or on the resilient core and a wireless transmitter configured to transmit signal representative of a sensed condition. The disc can include at least one mechanism configured to control, influence, or alter conditions of the resilient core.

“Our intuition told us the future will require the world to have more smart wireless devices with artificial intelligence (AI) so we moved quickly to start with AxioMed and we are grateful the US Patent Office rewarded us with this historic patent,” said Dr. Kingsley R Chin, the co-inventor on the patent and a board-certified professor of orthopedics and spine surgery as well as chief executive officer of KICVentures Group who owns AxioMed LLC.

“We have organically built AxioMed with no institutional funding which allows us to make out-of-the-box decisions like spending the cash to invest in a wireless smart AxioMed device,” said Aditya Humad, former JP Morgan Investment Banker and current CFO and Co-founder at KICVentures Group.

We are interviewing CEOs with public experience.

INVESTORS

Series A Now open in KICVentures Group.

INVESTOR@kicventures.com.

About AxioMed

AxioMed was founded in 2001 by surgeons at Cleveland Clinic and engineers who previously worked with Dr. Art Steffee and Acroflex viscoelastic disc replacement. The current AxioMed disc comprises of a proprietary silica-based viscoelastic material proven in extensive biomedical/biocompatible testing to mimic the human disc in all planes and 50+ years of longevity testing. The viscoelastic material is radiolucent and thus X-ray and MRI compatible. Over 800 discs have been implanted worldwide with zero failures or revisions. It is the only viscoelastic lumbar disc to complete a USA IDE clinical study with 10+ years of follow-up.

http://www.AxioMed.com

About KICVentures Group

Our founders have been investing in spine surgery 2000 makes us the most experienced healthcare investment holding company with the largest portfolio of medical device technologies focused on solutions for less invasive outpatient spine surgery. Our investment strategy is to acquire or invent disruptive technologies using our own capital or partner with private individual investors. This allows us the freedom to make quick and nimble decisions such as when we acquired AxioMed Viscoelastic Disc Technologies while other companies invested in spinal fusion.

http://www.KICVenturesGroup.com

Share article on social media or email:

CPESN® USA Announces New Agreement with Mobility Health


“We are thrilled to be able to expand our relationship with Mobility Health from our CPESN Ohio network to the rest of our local networks across the country,” said Troy Trygstad, PharmD, MBA, PhD, Executive Director of CPESN USA.

CPESN USA, a clinically integrated, nationwide organization of pharmacy networks created to advance community-based pharmacy practice, has entered into an agreement with Mobility Health, a biohealth diagnostic company with a mission to transform community-based healthcare, to encourage its pharmacies to utilize lab testing services provided by the Mason, Ohio-based lab.

Mobility Health began working with the CPESN® Ohio network in November 2021. The success of the program has encouraged both companies to expand beyond Ohio and include all 3,600 CPESN pharmacies across the country.

“We are thrilled to be able to expand our relationship with Mobility Health from our CPESN Ohio network to the rest of our local networks across the country,” said Troy Trygstad, PharmD, MBA, PhD, Executive Director of CPESN USA. “Mobility Health has been a collaborative and transparent partner – working together to figure out new ways to improve the care we provide to our patients.”

CPESN pharmacies collect COVID-19 / Flu A & B samples and send them directly to Mobility Health. Mobility Health covers overnight carrier fees and provides same or next day results to both the patient and the pharmacy. Mobility Health also helps ease the reporting burden placed on the pharmacies, which allows the pharmacy staff to focus on patient-care initiatives.

“Local, community-based pharmacies have long-standing and trusting relationships with their patients, and we want to be a resource to allow those relationships to flourish,” shared Scott Rueter, Director of Revenue Operations for Mobility Health. “We are excited to be able to expand our partnership with CPESN pharmacies across America and help them do what they do best, while also advancing our mission of providing advanced diagnostic services to all areas of the population, including those that are traditionally harder to reach, in the enduring fight against COVID-19 and other infectious diseases.”

For a list of pharmacies participating in the program, please visit: https://www.mobilityhealthlab.com/pharmacy-partners.

About CPESN® USA

CPESN® USA a clinically integrated, nationwide organization of pharmacy networks structured to advance community-based pharmacy practice. They empower community-based pharmacies that are deeply rooted within their community by fostering their ability to provide high quality, patient-centered enhanced services. CPESN® pharmacies integrate with other healthcare providers on the patient’s care team to coordinate medical treatment. The results are better medication adherence, higher patient satisfaction, and lower healthcare costs. You can find CPESN® Networks of pharmacy providers in 42 states across America. To learn more, please visit http://www.CPESN.com.

About Mobility Health

Mobility Health is a biohealth diagnostic company focused on providing accurate, rapid testing of infectious diseases to protect population health and safety. Mobility Health was established with a mission to transform community-based healthcare by deploying new technologies that eliminate barriers to rapid, advanced molecular testing and healthcare services. Founded in 2020 by Sandra Gunselman, Ph.D., a molecular biology and laboratory operations expert with a passion for reaching patients in need, the company combines cutting-edge laboratory technologies with mobile capabilities to offer unique services to underserved communities. For more information, visit http://www.mobilityhealthlab.com.

Share article on social media or email:

Amplify Surgical®, Inc. Hosts Fall Spine Symposium with Cadaver Lab – featuring dualPortal™ endoscopic and dualX® system


Amplify Surgical, Inc., a medical device company focused on innovative minimally invasive surgery for the lumbar spine, will be holding its Fall Spine Symposium, featuring dualPortal™ endoscopic and dualX® system, in New York City, New York on September 24, 2022. Amplify Surgical is partnering with expert surgeons from South Korea and the US to demonstrate one of the latest advancements in minimally invasive spine surgery, the dualPortal approach – a novel two-portal endoscopic technique. Surgeons are given two options to attend the symposium free of charge, either virtually or in-person.

The agenda will include both a didactic portion focused on dualPortal endoscopic spine surgery and dualX Dual Expanding Interbody Fusion System. There will be presentations and interactive sessions covering clinical outcomes of dualPortal and dualX. In the lab, faculty will showcase the power and versatility of the dualPortal endoscopic approach with dualX TLIF (dualLIF).

As their second symposium this year, this event marks a major milestone not only with Amplify Surgical, but in minimally invasive spine and endoscopic spine surgery alike, with expected attendance from surgeons all over the world. For registration information, please visit amplifysurgical.com/symposiumregistration.

The dualPortal technique is a novel two-portal endoscopic approach to the spine that allows surgeons to easily learn and perform a wider array of lumbar spine procedures than the conventional one-portal technique. It also provides flexibility to perform endoscopic lumbar fusions with dualX Dual Expanding Interbody Fusion System.

The dualX technology is comprised of a family of titanium expandable interbody devices designed to expand in both width and height, implanted in lateral lumbar interbody fusion (LLIF), posterior lumbar interbody fusion (PLIF) and transforaminal lumbar interbody fusion (TLIF) spinal procedures. The dualX portfolio contains varying footprints, heights and degrees of lordosis with post-expansion bone grafting to provide a customized anatomical fit for a clinically successful fusion environment.

To learn more about Amplify Surgical’s Fall Spine Symposium, dualX and dualPortal solutions, please visit our website at amplifysurgical.com or call us at 765-AMPLIFY (267-5439).

About Amplify Surgical, Inc.

Amplify Surgical is a privately held spinal device company located in Irvine, CA. The Company focuses on developing and commercializing innovative and minimally invasive technologies for spine surgery. Amplify Surgical is a portfolio company of IntuitiveX, a life science innovation incubator.

Share article on social media or email:

Dr. David Gennis, Psy.D., LMFT joins Moriah Behavioral Health


Dr. David Gennis, Psy.D., LMFT

“Dr. Gennis is an extremely experienced and welcome addition to our Operations team,” said Mendi Baron, LCSW, CEO and Founder of Moriah. “With his leadership, we will continue to expand our mood and anxiety clinical services throughout the country.”

Moriah Behavioral Health Co. (“Moriah”), a company focused on developing behavioral healthcare facilities and technology to change the mental health and eating disorder fields for the better, has announced the addition of Dr. David Gennis, Psy.D., LMFT as Regional Operations Director of the Mood and Anxiety Division.

Dr. Gennis has been a leader in the behavioral health industry for over 22 years. His extensive background and expertise in the mental health and substance abuse fields is widely known throughout the country. He has been a clinical director over every level of care in the mental industry. In addition, David is a published author, speaker, trainer, and passionate advocate for all people to have access to high quality behavioral health care and clinical services.

“Dr. Gennis is an extremely experienced and welcome addition to our Operations team,” said Mendi Baron, LCSW, CEO and Founder of Moriah. “With his leadership, we will continue to expand our mood and anxiety clinical services throughout the country.”

About Moriah Behavioral Health Co.

Moriah Behavioral Health Co. is a comprehensive healthcare organization dedicated to the treatment of mood and anxiety disorders as well as eating disorders, offered in warm, homelike settings. Moriah offers both gender specific and gender inclusive environments to allow all persons, their loved ones, and communities access to the resources needed. Moriah provides a full continuum of care, from residential through outpatient treatment to alumni services after discharge. Moriah programs include specialized treatment for adolescents and teens of all genders struggling with mood and anxiety disorders as well as, through separate divisions, adult and adolescent females struggling with eating disorders.

Share article on social media or email:

AlēvCare Hospice announces partnership with Texas Tech UHSC School of Nursing to educate tomorrow’s nurses


AlēvCare Hospice has partnered with the Texas Tech University Health Sciences Center (TTUHSC) School of Nursing to provide educational opportunities to their nursing students in the fields of hospice and end-of-life care.

In keeping with its mission to increase awareness of the benefits of hospice care, AlēvCare Hospice will provide the Texas Tech School of Nursing students with didactic classroom education as well as opportunities for the students to make observational visits with AlēvCare Hospice nurses during patient visits in the local community.

“AlēvCare Hospice is proud to support the Texas Tech School of Nursing and to provide educational opportunities for tomorrow’s nurses in hospice and end-of-life care,” said David Dowd, Founder and CEO of AlēvCare Hospice. “As an alumni of Texas Tech University, I’m excited about the opportunity to educate these young Red Raider nursing students about what hospice really is and what it isn’t. We look forward to the opportunity to support the Texas Tech School of Nursing and their nurses of tomorrow.”

TTHUSC School of Nursing Dean Tiffani Wise, R.N., DNP said, “As we educate our future nurses, it is important for students to be exposed to the many practice settings of nursing across the community. Partnering with AlēvCare Hospice provides a great opportunity for students to experience hospice and end-of-life care firsthand.”

About AlēvCare Hospice

AlēvCare Hospice, founded in 2017 by David Dowd and Craig Porter, who have both been residents of Tarrant County since the early 1970’s, is a locally-owned provider of hospice care in the greater DFW Area. Headquartered in Mansfield, TX, AlēvCare Hospice provides a broad range of palliative and support care services to alleviate pain, discomfort and concerns through comprehensive, loving support for people with terminal illnesses.

At AlēvCare Hospice, we understand the emotional and physical challenges associated with terminal illness for both the patient and their loved ones and our team is available at all hours to answer questions and help families to be comfortable caring for their loved one. Our care team is specially trained to provide patients with effective pain management techniques, called “palliative care” or “comfort care,” to enable people to be as free from pain and discomfort as possible. We are committed to providing people the ability to control the direction of their care and to helping people live with dignity, in comfort and peace, surrounded by their loved ones.

Services provided include specially trained nursing care; home health aides; counseling and social worker services; volunteer services; spiritual counseling and bereavement; child-life counseling services; occupational and speech therapy; a medical director that can collaborate with a patient’s personal physician; and medication for symptom and pain control. To learn more about AlēvCare Hospice, please visit us at http://www.alevcare.com. AlēvCare® Hospice is a Registered Trademark of C-Port, LLC Series B-Hospice.

About the Texas Tech University Health Sciences Center – School of Nursing

Since the first nursing class at TTUHSC in 1981, the school has expanded to offer the traditional Bachelor of Science in Nursing program across campuses in Lubbock and at additional campuses across the state. TTUHSC expanded into Mansfield, Texas in 2020 to meet the growing demand for baccalaureate-educated nurses in the State of Texas. TTUHSC expanded its traditional BSN program to the area, providing a resource for new nurses in Mansfield and the DFW area, critical to the operation of hospitals and clinics. This traditional bachelors program is for students without nursing credentials. These students will receive a current, highly advanced nursing education, developing skills and putting talents to use in both classroom and hands-on settings. Our traditional BSN does not have R.N. prerequisites—the perfect choice for those just starting their journey to a nursing career.

Texas Tech University Health Sciences Center School of Nursing is dedicated to training knowledgeable, compassionate nurses and nurse practitioners to meet the critical nursing shortage in Texas and across the nation. The traditional Bachelor of Science in Nursing program has more than 1,500 students across campuses in Lubbock, Amarillo, Odessa, Abilene, Dallas and Mansfield. Our multiple campuses give each nursing student a high-quality education with experienced faculty. The school is dedicated to creating new, innovative routes for students to complete their education. With accelerated Bachelor of Science in Nursing tracks, students can apply the knowledge they’ve already gained to completing their BSN in less time.

Share article on social media or email: